StockData
Tempest Therapeutics, Inc. logo

Tempest Therapeutics, Inc. (TPST) stock

TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.33−0.01 (-4.24%)

Close on Nov 17, 2026Market cap $4.85MP/E –Yield –

Tempest Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tempest Therapeutics's price to book ratio was 14.9× on Jul 31, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 0.5× to 37.3×, with a median of 1.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202614.9×+12.9
2025Dec 31, 20252.0×+0.1
2024Dec 31, 20241.9×−8.4
2023Oct 31, 202310.3×+9.8
2022Dec 30, 20220.5×−1.2
2021Oct 29, 20211.6×−35.6
2020Jan 31, 202037.3×+5.6
2019Dec 31, 201931.6×+29.7
2018Dec 31, 20181.9×−1.2
2017Dec 29, 20173.1×+1.2
2016Dec 30, 20161.9×−6.5
2015Dec 31, 20158.4×−60.6
2014Dec 31, 201469.0×+54.6
2013Dec 31, 201314.3×+0.7
2012Dec 31, 201213.6×–

More Tempest Therapeutics figures

See a number that looks wrong?